Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops …
Full SCNX analysis →
Competitive advantage assessment
Key strengths
Strong Liquidity BufferLiquidity position is strong (score 0.82), providing operational cushion.
Key risks
ROIC Below WACC or PeersROIC at 13.2th percentile suggests inefficient capital deployment.
Below-Peer Operating EfficiencyOperating margin at 0th percentile indicates below-peer efficiency.
The dashed ring is the peer median. Defense scores are percentile ranks
against peers, so 50 is roughly the typical company in this group.
Upgrade to unlock the signals and evidence behind each defense.
Premium access
Unlock full defense analysis
Get key signals, strengths, and risks for every moat dimension.
Where SCNX ranks in Healthcare: Providers, Plans & Distribution
Scienture Holdings, Inc. ranks #137 of 156
scored companies in Healthcare: Providers, Plans & Distribution by moat score — the top 88%.
The widest moat in the group is Veeva Systems Inc. (VEEV)
at 88/100.
Moat scores for companies ranked near SCNX in Healthcare: Providers, Plans & Distribution
Pricing power is the ability to raise prices without losing volume.
Cost Advantage
Score 2
· 15% of the moat score
A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.
Customer Stickiness
Score 3
· 15% of the moat score
Stickiness is what makes revenue repeat without being re-won every year.
Capital Efficiency
Score 8
· 18% of the moat score
Capital efficiency asks what the company earns on the money tied up in the business.
Resilience
Score 36
· 17% of the moat score
Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.
Scale & Market Position
Score 27
· 15% of the moat score
Scale matters only when it converts into economics.
Scienture Holdings, Inc. (SCNX) scores 15 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as weak. It ranks #137 of 156 scored companies in Healthcare: Providers, Plans & Distribution, the top 88%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 155 companies in Healthcare: Providers, Plans & Distribution. Its strongest defense is Resilience (36/100) and its weakest is Cost Advantage (2/100).
How does Scienture Holdings, Inc. compare with other Healthcare: Providers, Plans & Distribution companies?
Scienture Holdings, Inc. ranks #137 of 156 scored companies in Healthcare: Providers, Plans & Distribution by moat score. The widest moat in Healthcare: Providers, Plans & Distribution is Veeva Systems Inc. (VEEV) at 88/100. The companies ranked closest are MSP Recovery, Inc. (MSPRW) at 17 just above it and Aclarion, Inc. (ACON) at 15 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 155 companies in Healthcare: Providers, Plans & Distribution. The defenses are then weighted to produce the overall score out of 100.
Why is Scienture Holdings, Inc. scored with the Corporate Default template?
Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.
Which competitive defenses are measured for Scienture Holdings, Inc.?
The Corporate Default template measures 6 defenses, and SCNX scores: Pricing Power (14), Cost Advantage (2), Customer Stickiness (3), Capital Efficiency (8), Resilience (36), Scale & Market Position (27). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.